Biotechnology - Mergers & Acquisitions

Filter

Current filters:

Mergers & Acquisitions

Popular Filters

1 to 25 of 266 results

Bina Technologies is acquired by Roche

20-12-2014

Swiss pharma giant Roche has acquired Bina Technologies, a privately held company based in Redwood City,…

Bina TechnologiesBiotechnologyMergers & AcquisitionsRoche

Merck & Co in up to $375 million deal to acquire OncoEthix

Merck & Co in up to $375 million deal to acquire OncoEthix

19-12-2014

US pharma giant Merck & Co said yesterday that it has acquired, through a subsidiary, Swiss-based privately…

BiotechnologyMerck & CoMergers & AcquisitionsOncoEthixOncologyOTX015

Roche to acquire Austrian next-generation antibody firm Dutalys

Roche to acquire Austrian next-generation antibody firm Dutalys

19-12-2014

Swiss pharma giant Roche has agreed to acquire Dutalys, a privately held biotechnology company based…

BiotechnologyDutalysDutaMabMergers & AcquisitionsOncologyRoche

NetScientific invests in PDS Biotechnology

NetScientific invests in PDS Biotechnology

15-12-2014

UK-based life sciences investor NetScientific has made an undisclosed investment in privately-held US…

Antibiotics and Infectious diseasesBiotechnologyMergers & AcquisitionsNetScientificOncologyPDS BiotechnologyUK

Valneva and BliNK Therapeutics launch new biotech company

Valneva and BliNK Therapeutics launch new biotech company

12-12-2014

France-based biotech firm Valneva and privately-held UK company BliNK Therapeutics have created a private…

BiotechnologyBliNK BiomedicalBliNK TherapeuticsFinancialFranceMergers & AcquisitionsUKValneva

Sosei to acquire Japanese peptide technology company Jitsubo

Sosei to acquire Japanese peptide technology company Jitsubo

12-12-2014

Japanese biopharma company Sosei says its board of directors has resolved to acquire existing shares…

BiotechnologyJapanJitsuboMergers & AcquisitionsSosei

Official: Merck & Co to acquire Cubist for $8.4 billion

Official: Merck & Co to acquire Cubist for $8.4 billion

08-12-2014

Confirming weekend speculation and rumors, US pharma giant Merck & Co this morning said it has entered…

Antibiotics and Infectious diseasesBiotechnologyCubicinCubist PharmaceuticalsMerck & CoMergers & AcquisitionsZerbaxa

Cocrystal Pharma and RFS Pharma complete merger

28-11-2014

USA-based biotech firm Cocrystal Pharma has announced the closing of its merger with RFS Pharma, a privately…

Anti-viralsBiotechnologyCocrystal PharmaMergers & AcquisitionsRFS Pharma

Valeant buys NicOx’ US ophthalmic diagnostics unit

17-11-2014

Ophthalmology-focused French biotech firm NicOx says that Canada’s Valeant Pharmaceuticals International…

BiotechnologyMergers & AcquisitionsNicOxOphthalmicsUSAValeant Pharmaceuticals InternationalVesneo

Bristol-Myers enters option agreement to acquire Danish firm

Bristol-Myers enters option agreement to acquire Danish firm

03-11-2014

US pharma major Bristol-Myers Squibb has entered into an exclusive option agreement to buy Denmark-based…

BiotechnologyBristol-Myers SquibbGalecto BiotechMergers & AcquisitionsRespiratory and PulmonaryTD139

Actinogen acquires Edinburgh BioQuarter spin-out Corticrine

Actinogen acquires Edinburgh BioQuarter spin-out Corticrine

31-10-2014

Australian biotech firm Actinogen has acquired Edinburgh BioQuarter spin-out, Corticrine.

ActinogenBiotechnologyCorticrineEdinburgh BioQuarterMergers & AcquisitionsNeurological

Fujifilm to expand biopharma CMO business with acquisition of Kalon

29-10-2014

Fujifilm Diosynth Biotechnologies USA, a subsidiary of Japanese digital camera and medical equipment…

BiotechnologyFujifilmFujifilm Diosynth BiotechnologiesKalon BiotherapeuticsMergers & AcquisitionsVaccines

Bristol-Myers enters option deal to acquire F-star Alpha and FS102

28-10-2014

US pharma major Bristol-Myers Squibb has entered into an agreement that provides it with the exclusive…

BiotechnologyBristol-Myers SquibbF-star AlphaFS102Mergers & AcquisitionsOncology

Sutro Biopharma and Celgene expand accord; add buyout option

23-10-2014

Sutro Biopharma today announced it has entered into a strategic collaboration and option agreement with…

BiotechnologyCelgene Corp.LicensingMergers & AcquisitionsOncologySutro Biopharma

MorphoSys gets milestone from Novartis; acquires new technology

21-10-2014

German company MorphoSys says it has received a milestone payment from Novartis in connection with the…

BiotechnologyLanthio PharmalanthipeptideMergers & AcquisitionsMorphoSysNovartisOphthalmicsResearch

Virax to acquire AKTivate and deep AKT inhibitor portfolio

17-10-2014

Australian biotechnology company Virax Holdings will acquire US oncology company AKTivate Therapeutics…

AKTivate TherapeuticsBiotechnologyMergers & AcquisitionsOncologyPathway OncologyVirax Holdings

Prima BioMed to acquire Immutep for $28 million

Prima BioMed to acquire Immutep for $28 million

03-10-2014

France-based Immutep, a late-stage private biopharmaceutical company in the rapidly growing field of…

BiotechnologyFranceImmunologicalsImmutepMergers & AcquisitionsOncologyPrima BioMed

Sigma-Aldrich acquires Cell Marque to grow antibody portfolio

Sigma-Aldrich acquires Cell Marque to grow antibody portfolio

03-10-2014

USA-based life sciences company Sigma-Aldrich has entered into an agreement to acquire US antibody company…

AnatomyBiologyBiotechnologyImmunologicalsMergers & AcquisitionsProtein methodsSigma-AldrichUSA

WuXi PharmaTech acquires XenoBiotic Labs

WuXi PharmaTech acquires XenoBiotic Labs

01-10-2014

Chinese pharma, biotech and devices firm WuXi PharmaTech says it has acquired XenoBiotic Laboratories,…

BiotechnologyChinaMergers & AcquisitionsWuXi PharmaTech

Daiichi Sankyo to buy Ambit Biosciences for up to $410 million

Daiichi Sankyo to buy Ambit Biosciences for up to $410 million

29-09-2014

Daiichi Sankyo and Ambit Biosciences have entered into a definitive merger agreement under which Daiichi…

Ambit BiosciencesBiotechnologyDaiichi SankyoJapanMergers & AcquisitionsOncologyquizartinib

Acorda Therapeutics to acquire Civitas for $525 million

24-09-2014

US biotech firm Acorda Therapeutics has entered into an agreement to acquire Civitas Therapeutics, a…

Acorda TherapeuticsBiotechnologyCivitas TherapeuticsCVT-301Mergers & AcquisitionsNeurological

ReproCELL acquires the iPS Cell Business unit of Stemgent

10-09-2014

Japan-based ReproCELL is to acquire the iPS Cell Business unit of Privately-held US firm Stemgent. This…

BiotechnologyMergers & AcquisitionsReproCELLStemgent

Eisai divests US Zonegran rights to Concordia

Eisai divests US Zonegran rights to Concordia

07-09-2014

Japanese drugmaker Eisai (TYO: 4523) says its US subsidiary has entered into an agreement to divest its…

BiotechnologyConcordia PharmaceuticalsEisaiMergers & AcquisitionsNeurologicalUSAZonegran

Soligenix acquires Ph III-ready oncology clinical program

Soligenix acquires Ph III-ready oncology clinical program

05-09-2014

US clinical-stage biopharma firm Soligenix has acquired a novel orphan drug candidate, known as SGX301…

BiotechnologyhypericinMergers & AcquisitionsOncologySGX301Soligenix

1 to 25 of 266 results

Back to top